• News
  • Medical

Organovo Holdings, ZenBio partnering for 3-D tissue

San Diego-based Organovo Holdings Inc. (OTCQX: ONVO) and ZenBio Inc. are partnering to produce three-dimensional human tissues for drug discovery and advanced tissue therapies.

Organovo Holdings is a creator and manufacturer of functional, three-dimensional human tissues for medical research and therapeutic applications.

ZenBio Inc. provides advanced cell-based solutions and services.

ZenBio will provide validated cellular inputs for use by Organovo with its NovoGen bioprinting technology to enable the generation of living, three-dimensional tissues that reproduce the architectural and functional features of tissues inside the human body.

The resulting 3-D tissue models may lead to advances in medical research, drug discovery and development, as well as direct therapies and transplantation, according to Organovo.

User Response
0 UserComments

Organovo Holdings Inc.

Company Website

6275 Nancy Ridge Dr. Ste., 110
San Diego, CA 92121

Organovo Holdings Inc. Executive(s):

Keith Murphy

  • Chairman, Chief Executive Officer

Barry Michaels

  • Chief Financial Officer